These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1461620)

  • 1. Potential applications of high-dose megestrol acetate in breast cancer.
    Abrams JS; Gutheil J; Aisner J
    Oncology; 1992; 49 Suppl 2():12-7. PubMed ID: 1461620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose megestrol acetate in the treatment of advanced breast cancer.
    Tchekmedyian NS; Tait N; Abrams J; Aisner J
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):44-9. PubMed ID: 3368800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose megestrol acetate. A possible treatment for cachexia.
    Tchekmedyian NS; Tait N; Moody M; Aisner J
    JAMA; 1987 Mar; 257(9):1195-8. PubMed ID: 3806918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appetite stimulation with megestrol acetate in cachectic cancer patients.
    Tchekmedyian NS; Tait N; Moody M; Greco FA; Aisner J
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):37-43. PubMed ID: 3798127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of high-dose megestrol acetate: potential applications in cachexia.
    Aisner J; Tchekmedyian NS; Tait N; Parnes H; Novak M
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):68-75. PubMed ID: 3285486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose megestrol acetate in the treatment of postmenopausal women with advanced breast cancer.
    Tchekmedyian NS; Tait N; Aisner J
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):20-5. PubMed ID: 3798125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer.
    Cruz JM; Muss HB; Russell G
    Oncology; 1992; 49 Suppl 2():8-11. PubMed ID: 1461630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy.
    Cruz JM; Muss HB; Brockschmidt JK; Evans GW
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):63-7. PubMed ID: 2259928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.
    Kornblith AB; Hollis DR; Zuckerman E; Lyss AP; Canellos GP; Cooper MR; Herndon JE; Phillips CA; Abrams J; Aisner J
    J Clin Oncol; 1993 Nov; 11(11):2081-9. PubMed ID: 8229122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megestrol acetate in advanced breast carcinoma.
    Espie M
    Oncology; 1994 Oct; 51 Suppl 1():8-12. PubMed ID: 7970508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose megestrol acetate for the treatment of advanced breast cancer: dose and toxicities.
    Aisner J; Tchekmedyian NS; Moody M; Tait N
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):48-55. PubMed ID: 3589708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of high-dose progestins in breast cancer.
    Abrams JS; Parnes H; Aisner J
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):68-72. PubMed ID: 2148027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megestrol acetate: first-line therapy for advanced breast cancer.
    Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Economou SG
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):15-9. PubMed ID: 3798124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
    Paterson AH; Hanson J; Pritchard KI; Sansregret E; Dahrouge S; McDermot RS; Fine S; White DF; Trudeau M; Stewart DJ
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):52-62. PubMed ID: 2259927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
    Loprinzi CL; Michalak JC; Schaid DJ; Mailliard JA; Athmann LM; Goldberg RM; Tschetter LK; Hatfield AK; Morton RF
    J Clin Oncol; 1993 Apr; 11(4):762-7. PubMed ID: 8478668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose progestin therapy for metastatic breast cancer.
    Muss HB; Cruz JM
    Ann Oncol; 1992 Aug; 3 Suppl 3():15-20. PubMed ID: 1390312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
    Morgan LR
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):43-7. PubMed ID: 3975652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of megestrol acetate for the treatment of advanced breast cancer.
    Sedlacek SM
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):3-13. PubMed ID: 3285483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megestrol acetate: clinical experience.
    Schacter L; Rozencweig M; Canetta R; Kelley S; Nicaise C; Smaldone L
    Cancer Treat Rev; 1989 Mar; 16(1):49-63. PubMed ID: 2471590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
    Buzdar A; Jonat W; Howell A; Jones SE; Blomqvist C; Vogel CL; Eiermann W; Wolter JM; Azab M; Webster A; Plourde PV
    J Clin Oncol; 1996 Jul; 14(7):2000-11. PubMed ID: 8683230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.